Surmodics, Inc. (SRDX): Price and Financial Metrics

Surmodics, Inc. (SRDX): $23.28

0.41 (+1.79%)

POWR Rating

Component Grades














  • SRDX scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.49% of US stocks.
  • SRDX's strongest trending metric is Stability; it's been moving down over the last 177 days.
  • SRDX's current lowest rank is in the Growth metric (where it is better than 15.97% of US stocks).

SRDX Stock Summary

  • SRDX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.92 -- higher than only 15.63% of US-listed equities with positive expected earnings growth.
  • With a year-over-year growth in debt of 194.95%, SURMODICS INC's debt growth rate surpasses 93.16% of about US stocks.
  • Over the past twelve months, SRDX has reported earnings growth of -873.95%, putting it ahead of merely 2.18% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to SURMODICS INC, a group of peers worth examining would be KLIC, ICPT, ACAD, SPRO, and PALT.
  • Visit SRDX's SEC page to see the company's official filings. To visit the company's web site, go to

SRDX Valuation Summary

  • In comparison to the median Healthcare stock, SRDX's EV/EBIT ratio is 254.55% lower, now standing at -10.2.
  • SRDX's EV/EBIT ratio has moved down 49.7 over the prior 243 months.

Below are key valuation metrics over time for SRDX.

Stock Date P/S P/B P/E EV/EBIT
SRDX 2023-03-24 2.6 2.4 -8.0 -10.2
SRDX 2023-03-23 2.4 2.3 -7.5 -9.5
SRDX 2023-03-22 2.4 2.3 -7.5 -9.6
SRDX 2023-03-21 2.5 2.3 -7.7 -9.8
SRDX 2023-03-20 2.4 2.3 -7.5 -9.6
SRDX 2023-03-17 2.4 2.3 -7.6 -9.6

SRDX Growth Metrics

    Its 5 year revenue growth rate is now at 37.07%.
  • Its 2 year revenue growth rate is now at -3.62%.
  • Its 5 year net cashflow from operations growth rate is now at -33.79%.
Over the past 34 months, SRDX's revenue has gone up $1,283,000.

The table below shows SRDX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 101.881 -20.999 -32.305
2022-09-30 99.951 -17.223 -27.274
2022-06-30 97.934 -13.834 -12.835
2022-03-31 96.953 -7.582 -10.471
2021-12-31 105.842 12.633 1.699
2021-09-30 105.136 15.389 4.237

SRDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SRDX has a Quality Grade of B, ranking ahead of 94.57% of graded US stocks.
  • SRDX's asset turnover comes in at 0.604 -- ranking 71st of 186 Medical Equipment stocks.
  • MMSI, POAI, and OSUR are the stocks whose asset turnover ratios are most correlated with SRDX.

The table below shows SRDX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.604 0.837 0.071
2021-03-31 0.632 0.848 0.115
2020-12-31 0.578 0.832 -0.017
2020-09-30 0.588 0.839 -0.016
2020-06-30 0.648 0.854 0.060
2020-03-31 0.648 0.861 0.063

SRDX Price Target

For more insight on analysts targets of SRDX, see our SRDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $76.25 Average Broker Recommendation 1.25 (Strong Buy)

SRDX Stock Price Chart Interactive Chart >

Price chart for SRDX

SRDX Price/Volume Stats

Current price $23.28 52-week high $45.85
Prev. close $22.87 52-week low $16.00
Day low $22.82 Volume 17,232
Day high $23.32 Avg. volume 184,500
50-day MA $23.37 Dividend yield N/A
200-day MA $31.54 Market Cap 328.83M

Surmodics, Inc. (SRDX) Company Bio

SurModics Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company operates through two segments, Medical Device and In Vitro Diagnostics. The company was founded in 1979 and is based in Eden Prairie, Minnesota.

SRDX Latest News Stream

Event/Time News Detail
Loading, please wait...

SRDX Latest Social Stream

Loading social stream, please wait...

View Full SRDX Social Stream

Latest SRDX News From Around the Web

Below are the latest news stories about SURMODICS INC that investors may wish to consider to help them evaluate SRDX as an investment opportunity.

Surmodics (SRDX) Gets FDA's Formal Feedback About SurVeil DCB

Surmodics' (SRDX) receipt of the FDA's positive formal feedback regarding its PMA application for the SurVeil DCB looks promising.

Yahoo | March 29, 2023

Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

EDEN PRAIRIE, Minn., March 28, 2023--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that it has received formal feedback from the Food and Drug Administration (FDA; the Agency) related to its proposed approach to submit an amended premarket approval (PMA) application for the SurVeil™ drug-coated balloon (DCB).

Yahoo | March 28, 2023

SurModics (SRDX) Moves 5.4% Higher: Will This Strength Last?

SurModics (SRDX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Yahoo | March 17, 2023

SurModics (SRDX) Down 37.2% Since Last Earnings Report: Can It Rebound?

SurModics (SRDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | March 8, 2023

Surmodics to Participate in Upcoming Investor Conferences in March

EDEN PRAIRIE, Minn., March 08, 2023--Management will make a presentation to the investment community at the Oppenheimer Healthcare Conference on Wednesday, March 15, at 9:40 a.m. CT.

Yahoo | March 8, 2023

Read More 'SRDX' Stories Here

SRDX Price Returns

1-mo 6.16%
3-mo -31.77%
6-mo -23.42%
1-year -48.64%
3-year -30.13%
5-year -38.82%
YTD -31.77%
2022 -29.14%
2021 10.64%
2020 5.04%
2019 -12.34%
2018 68.79%

Continue Researching SRDX

Here are a few links from around the web to help you further your research on Surmodics Inc's stock as an investment opportunity:

Surmodics Inc (SRDX) Stock Price | Nasdaq
Surmodics Inc (SRDX) Stock Quote, History and News - Yahoo Finance
Surmodics Inc (SRDX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8078 seconds.